Validation of a Semi-automatized Method to Detect Cyclic Hyperinflation on CT-scan in ARDS (CT4-ARDS)

August 20, 2025 updated by: Hospices Civils de Lyon

This study aims to validate a semi-automatized method to quantify cyclic hyperinflation on CT-scan of ARDS patients.

The gold standard will be cyclic hyperinflation assessed on the same CT scan, using manual segmentation of the lung.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69004
        • Croix Rousse Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ARDS patients defined by the Berlin definition
  • invasive mechanical ventilation with an arterial oxygen pressure (PaO2)/inspired fraction of oxygen (FiO2) ratio ≤ 200 mm Hg
  • Indication of CT scan identified by the clinician in charge
  • oesophageal catheter already inserted

Exclusion Criteria:

  • requirement of contrast agent for a chest CT-scan
  • ARDS criteria present for more than 72 hours
  • Chronic Obstructive Pulmonary Disease (COPD) on a previous lung function test
  • pneumothorax or bronchopleural fistula
  • patient without both sedation and neuromuscular blocking agents
  • contra-indication to transport to the imaging facility
  • treatment with extracorporeal membrane oxygenation or extracorporeal carbon dioxide (CO2) removal
  • Latex or curare allergy
  • patient previously included in the study
  • pregnancy
  • patient under limitation of care
  • patient under an exclusion period following inclusion in another clinical trial
  • patient under a legal protective measure
  • patient unaffiliated with social security
  • inform consent not obtained by next of kin

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ARDS patients
All the patients will be evaluated with the same procedure, as the study relates to evaluation of the diagnostic performance of a semi-automated method to detect cyclic hyperinflation on CT scan

The patient will be installed on the scanner bed. Two series of tomographic sections will be acquired: one during an expiratory break, the other during an inspiratory pause.

cyclic hyperinflation measured by semi-automatic segmentation and by manual segmentation

Other Names:
  • CT measurements

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cyclic hyperinflation measured by manual segmentation
Time Frame: 2 hours after inclusion
Bias and precision of semi-automated measure will be assessed with the Bland and Altman Technique, using cyclic hyperinflation by manual segmentation as a reference
2 hours after inclusion
cyclic hyperinflation measured by semi-automated segmentation
Time Frame: 2 hours after inclusion
Bias and precision of semi-automated measure will be assessed with the Bland and Altman Technique, using cyclic hyperinflation by manual segmentation as a reference
2 hours after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence of cyclic hyperinflation on CT scan
Time Frame: 2 hours after inclusion
cyclic hyperinflation assessed by manual segmentation on CT scan
2 hours after inclusion
area under receiver operating characteristic (ROC) curve of respiratory system driving pressure to detect cyclic hyperinflation assessed by manual segmentation
Time Frame: 2 hours after inclusion
2 hours after inclusion
area under ROC curve of transpulmonary driving pressure to detect cyclic hyperinflation assessed by manual segmentation
Time Frame: 2 hours after inclusion
2 hours after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean Christophe RICHARD, Hospices Civils de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • E. Dávila Serrano, François Dhelft, Laurent Bitker, Jean-Christophe Richard, Maciej Orkisz. Software for CT-image Analysis to Assist the Choice of Mechanical-ventilation Settings in Acute Respiratory Distress Syndrome. 2020 International Conference on Computer Vision and Graphics (ICCVG 2020), Sep 2020, Varsovie, Poland. ff10.1007/978-3-030-59006-2_5ff. ffhal-02887264

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 21, 2019

Primary Completion (Actual)

February 16, 2021

Study Completion (Actual)

February 16, 2021

Study Registration Dates

First Submitted

March 8, 2019

First Submitted That Met QC Criteria

March 8, 2019

First Posted (Actual)

March 11, 2019

Study Record Updates

Last Update Posted (Actual)

August 22, 2025

Last Update Submitted That Met QC Criteria

August 20, 2025

Last Verified

August 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome (ARDS)

Clinical Trials on ARDS patients

Subscribe